Related references
Note: Only part of the references are listed.130 Overall survival benefit and impact on skeletal-related events for radium-223 chloride (Alpharadin) in the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases: A phase III randomized trial (ALSYMPCA)
C. Parker et al.
EUROPEAN UROLOGY SUPPLEMENTS (2012)
Blood plasma model predictions for the proposed bone-seeking radiopharmaceutical [117mSn]Sn(IV)-N,N′,N′-trimethylenephosphonate-poly(ethyleneimine)
David R. Jansen et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Hydroxyapatite Chemisorption of N,N′,N′-Trimethylenephosphonate-Poly(ethyleneimine) (PEI-MP) Combined with Sn2+ or Sn4+
David R. Jansen et al.
LANGMUIR (2009)
Development of [90Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastases
Kazuma Ogawa et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Comparison of Systemic Toxicities of 177Lu-DOTMP and 153Sm-EDTMP Administered Intravenously at Equivalent Skeletal Doses to Normal Dogs
Jeffrey N. Bryan et al.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY (2009)
Paper radiochromatography for evaluation of radiochemical purity and stability of [186gRe]Re-HEDP in biological samples after human administration
S. Ridone et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2008)
Bone biology and physiology: Implications for novel osteoblastic osteosarcoma treatments?
John G. Spangler
MEDICAL HYPOTHESES (2008)
31P NMR study of the valence stability of tin in its 1-hydroxyethylene-diphosphonate (HEDP) and N,N′,N′-trimethylenephosphonate-polyethyleneimine (PEI-MP) complexes
David R. Jansen et al.
POLYHEDRON (2008)
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer:: a randomised, multicentre, placebo-controlled phase II study
Sten Nilsson et al.
LANCET ONCOLOGY (2007)
Clinical features of metastatic bone disease and risk of skeletal morbidity
Robert E. Coleman
CLINICAL CANCER RESEARCH (2006)
Hydroxybisphosphonate-containing polymeric drug-delivery systems designed for targeting into bone tissue
Martin Hruby et al.
JOURNAL OF APPLIED POLYMER SCIENCE (2006)
Preliminary study of metabolic radiotherapy with Re-188 via small animal imaging
A Antoccia et al.
NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS (2006)
Exploiting the enhanced permeability and retention effect for tumor targeting
Arun K. Iyer et al.
DRUG DISCOVERY TODAY (2006)
First clinical experience with α-emitting radium-223 in the treatment of skeletal metastases
S Nilsson et al.
CLINICAL CANCER RESEARCH (2005)
Targeting of therapeutic agents to bone to treat metastatic cancer
CM Bagi
ADVANCED DRUG DELIVERY REVIEWS (2005)
188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases
A El-Mabhouh et al.
APPLIED RADIATION AND ISOTOPES (2005)
Spontaneous and genetically engineered animal models: use in preclinical cancer drug development
K Hansen et al.
EUROPEAN JOURNAL OF CANCER (2004)
Comparison of the predicted in vivo behaviour of the Sn(II)-APDDMP complex and the results as studied in a rodent model
JR Zeevaart et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Polymeric prodrugs
K Hoste et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin
T Morçöl et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases
K Liepe et al.
BRITISH JOURNAL OF CANCER (2003)
High-yield synthesis of the terminal 188ReN multiple bond from generator-produced [188ReO4]-
A Boschi et al.
NUCLEAR MEDICINE AND BIOLOGY (2003)
A thermodynamic approach, using speciation studies, towards the evaluation and design of bone-seeking radiopharmaceuticals as illustrated for Sn-117m(II)-PEI-MP
JR Zeevaart et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2003)
Bone-seeking therapeutic radiopharmaceuticals
SC Srivastava
BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY (2002)
177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation
T Das et al.
APPLIED RADIATION AND ISOTOPES (2002)
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: Low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases
PM Anderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Novel therapeutic approaches to cancer patients with bone metastasis
R Maisano et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2001)
Rhenium-188 HEDP to treat painful bone metastases
SJ Li et al.
CLINICAL NUCLEAR MEDICINE (2001)
Efficacy of Re-188-labelled sulphur colloid on prolongation of survival time in melanoma-bearing animals
FD Chen et al.
NUCLEAR MEDICINE AND BIOLOGY (2001)
Histologic study of effects of radiation synovectomy with Rhenium-188 microsphere
SJ Wang et al.
NUCLEAR MEDICINE AND BIOLOGY (2001)
Synthesis of a new bisphosphonic acid ligand (SEDP) and preparation of a 188Re-(Sn)SEDP bone seeking radiotracer
EC Lisic et al.
NUCLEAR MEDICINE AND BIOLOGY (2001)
Radionuclide therapy with bone-seeking compounds: Monte Carlo calculations of dose-volume histograms for bone marrow in trabecular bone
Y Kvinnsland et al.
PHYSICS IN MEDICINE AND BIOLOGY (2001)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
Metal-ion speciation in blood plasma incorporating the tetraphosphonate, N,N-dimethylenephosphonate-1-hydroxy-4-aminopropilydenediphosphonate (APDDMP), in therapeutic radiopharmaceuticals
JR Zeevaart et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2001)
Systemic radiopharmaceutical therapy of painful osteoblastic metastases
EB Silberstein
SEMINARS IN RADIATION ONCOLOGY (2000)
Physical and chemical properties of radionuclide therapy
BW Wessels et al.
SEMINARS IN RADIATION ONCOLOGY (2000)
Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases
H Palmedo et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Conformal radiotherapy for prostate cancer
GE Hanks
ANNALS OF MEDICINE (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
